Activation of Vitamin D Receptor Pathway Enhances Differentiating Capacity in Acute Myeloid Leukemia with Isocitrate Dehydrogenase Mutations
Marie Sabatier(Inserm), Jean‐Emmanuel Sarry(Inserm)
Cited by 5
Related Papers
Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia
|The Journal of Experimental Medicine|2021|121
Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells
|Nature Communications|2021|63
Adrenomedullin-CALCRL Axis Controls Relapse-Initiating Drug Tolerant Acute Myeloid Leukemia Cells
|bioRxiv (Cold Spring Harbor Laboratory)|2020|6